CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+23.06%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$849M
AUM Growth
+$849M
(-11%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-26.39%
Top 10 Holdings %
Top 10 Hldgs %
85.18%
Holding
28
New
4
Increased
5
Reduced
7
Closed
8
Top Buys
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$91.9M |
| 2 |
United Therapeutics
UTHR
|
$86.9M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$73.9M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$69.5M |
| 5 |
Pacira BioSciences
PCRX
|
$44.3M |
Sector Composition
| 1 | Healthcare | 99.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $100M | 11.79% | 24,824,280 -228,100 | -0.9% | -$919K |
|
2
Globus Medical
GMED
$8.27B
| $94M | 11.07% | 2,835,000 -100,000 | -3% | -$3.31M |
|
3
Myriad Genetics
MYGN
$593M
| $84.4M | 9.95% | 3,267,487 +291,131 | +10% | +$7.52M |
|
|
AAAP
4
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $73M | 8.6% | 1,869,507 +557,652 | +43% | +$21.8M |
|
5
PTC Therapeutics
PTCT
$3.92B
| $72.3M | 8.52% | +3,946,009 | New | +$72.3M |
|
6
AtriCure
ATRC
$1.84B
| $69.1M | 8.14% | 2,849,185 -37,169 | -1% | -$901K |
|
7
Corcept Therapeutics
CORT
$7.35B
| $68.5M | 8.07% | 5,804,340 +634,700 | +12% | +$7.49M |
|
|
LJPC
8
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $59.9M | 7.06% | 2,012,519 +591,777 | +42% | +$17.6M |
|
|
CLVS
9
DELISTED
Clovis Oncology, Inc.
CLVS
| $51M | 6.01% | 544,843 -789,624 | -59% | -$73.9M |
|
|
KERX
10
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $50.6M | 5.97% | +7,005,041 | New | +$50.6M |
|
11
Travere Therapeutics
TVTX
$1.56B
| $47.3M | 5.57% | 2,438,540 +306,400 | +14% | +$5.94M |
|
|
CVRS
12
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $28.1M | 3.31% | 15,114,872 | – | – |
|
|
SPPI
13
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $15.1M | 1.77% | +2,020,583 | New | +$15.1M |
|
14
Pacific Biosciences
PACB
$393M
| $13.6M | 1.61% | +3,832,713 | New | +$13.6M |
|
15
Vericel Corp
VCEL
$1.83B
| $8.47M | 1% | 2,566,084 -416,856 | -14% | -$1.38M |
|
16
ANI Pharmaceuticals
ANIP
$2.03B
| $6.69M | 0.79% | 143,003 | – | – |
|
17
ADMA Biologics
ADMA
$4.12B
| $4.71M | 0.56% | 1,273,933 | – | – |
|
|
BIOL
18
DELISTED
Biolase, Inc.
BIOL
| $1.12M | 0.13% | 1,152,737 -108,550 | -9% | -$105K |
|
|
SPNE
19
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $618K | 0.07% | 53,627 -34,500 | -39% | -$398K |
|
|
SBBP
20
DELISTED
Strongbridge Biopharma plc.
SBBP
| $72K | 0.01% | 10,000 | – | – |
|
21
Acadia Healthcare
ACHC
$2.12B
| – | – | -310,666 | Closed | -$13.5M |
|
|
22
Pacira BioSciences
PCRX
$1.2B
| – | – | -972,535 | Closed | -$44.3M |
|
|
23
United Therapeutics
UTHR
$13.8B
| – | – | -642,168 | Closed | -$86.9M |
|
|
ACOR
24
DELISTED
Acorda Therapeutics, Inc.
ACOR
| – | – | -619,419 | Closed | -$13M |
|
|
MNK
25
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – | -1,558,944 | Closed | -$69.5M |
|